Lymphoma risk in systemic lupus: effects of treatment versus disease activity
AE Clarke1, S Bernatsky1, KH Costenbader2, MB Urowitz3, DD Gladman3, PR Fortin4, M Petri5, S Manzi6, DA Isenberg7, A Rahman7, D Wallace8, C Gordon9, C Peschken10, MA Dooley11, EM Ginzler12, C Aranow13, SM Edworthy14, O Nived15, S Jacobsen16, G Ruiz-Irastorza17, E Yelin18, SG Barr14, L Criswell18, G Sturfelt15, L Dreyer16, I Blanco19, L Gottesman20, CH Feldman2, R Ramsey-Goldman21
1Research Institute of the McGill University Health Centre, Montreal, Canada
2Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
3Toronto Western Hospital and University of Toronto, Toronto, Canada
4University of Laval, Canada
5Johns Hopkins University School of Medicine, Baltimore, USA
6West Penn Allegheny Health System, Pittsburgh, USA
7University College of London, UK
8Cedars-Sinai/UCLA, Los Angeles, USA
9University of Birmingham, UK
10University of Manitoba, Winnipeg, Canada
11University of North Carolina at Chapel Hill, USA
12SUNY Downstate Medical Center, Brooklyn, USA
13Feinstein Institute for Medical Research, Manhasset, USA
14The University of Calgary, Canada
15University Hospital - Lund, Sweden
16Copenhagen University Hospital, Copenhagen, Denmark
17Hospital de Cruces, UPV/EHU, Barakaldo, Spain
18University of California, San Francisco, USA
19Albert Einstein College of Medicine, Bronx, USA
20SUNY - Downstate Medical Center, Brooklyn, USA
21Northwestern University Feinberg School of Medicine, Chicago, USA